This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Berberis aquifolium
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
The Pacific Northwest species containing berberine; antimicrobial activity comparable to tetracycline for GI infections; antiprotozoal against Giardia and Candida.
The Pacific Northwest species containing berberine; antimicrobial activity comparable to tetracycline for GI infections; antiprotozoal against Giardia and Candida. Key active compounds include Berberine, Berbamine, Oxyacanthine.
Berberine, along with Berbamine and Oxyacanthine, are the primary bioactive compounds in Berberine Source. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth, promotes tissue regeneration and modulates local inflammation.
Antimicrobial for GI infections (berberine)
Supported by clinical evidence; more large-scale trials would strengthen findings
Psoriasis and skin inflammation
Supported by clinical evidence; more large-scale trials would strengthen findings
Anti-diabetic via berberine
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Liver and digestive support in Native American medicine
Based on traditional use; clinical evidence limited
Skin diseases and psoriasis
Based on traditional use; clinical evidence limited
Antimicrobial for intestinal infections
Based on traditional use; clinical evidence limited
Found an error or have a correction for Berberine Source?
Report an Issue →